Whalen Wealth Management Inc. Invests $240,000 in Alpha Teknova, Inc. (NASDAQ:TKNO)

Whalen Wealth Management Inc. acquired a new position in shares of Alpha Teknova, Inc. (NASDAQ:TKNO) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 28,744 shares of the company’s stock, valued at approximately $240,000. Whalen Wealth Management Inc. owned approximately 0.05% of Alpha Teknova at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of TKNO. Roubaix Capital LLC purchased a new stake in shares of Alpha Teknova during the 3rd quarter worth about $2,015,000. Point72 Asset Management L.P. bought a new stake in shares of Alpha Teknova in the 3rd quarter valued at approximately $1,483,000. State Street Corp increased its holdings in Alpha Teknova by 249.3% in the third quarter. State Street Corp now owns 76,645 shares of the company’s stock worth $371,000 after buying an additional 54,700 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in Alpha Teknova by 24.4% during the third quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after acquiring an additional 36,914 shares in the last quarter. Institutional investors and hedge funds own 13.81% of the company’s stock.

Alpha Teknova Price Performance

NASDAQ TKNO opened at $8.35 on Thursday. The company has a 50 day moving average price of $7.90 and a two-hundred day moving average price of $5.80. Alpha Teknova, Inc. has a 12-month low of $1.15 and a 12-month high of $9.72. The stock has a market capitalization of $445.12 million, a PE ratio of -11.28 and a beta of 0.34. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.04). Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The business had revenue of $9.58 million during the quarter, compared to the consensus estimate of $9.30 million. During the same quarter in the prior year, the company posted ($0.34) earnings per share. As a group, equities analysts predict that Alpha Teknova, Inc. will post -0.58 earnings per share for the current fiscal year.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.